Meetings & Events

LYUMJEV™ (insulin lispro-aabc) Injection

August 27, 2020

Product Theater Details: 3:35–4:35 PM EDT on Friday, September 11, 2020

Presenter: Thomas C. Blevins, MD
Texas Diabetes and Endocrinology

This program will discuss LYUMJEV, a mealtime insulin option for adult patients living with type 1 and type 2 diabetes. Attendees will join a discussion on the efficacy, safety profile, and appropriate prescribing of this therapy. In addition, this program will review patient initiation on LYUMJEV regarding dosing and administration. There will also be an opportunity to ask the faculty questions about the data presented.

This program is sponsored by and the speaker is presenting on behalf of Lilly Diabetes. It is being presented consistent with FDA guidelines and is not approved for continuing education credit.

Last Updated:
Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!